Effects of Tiotropium With and Without Formoterol on Airflow Obstruction and Resting Hyperinflation in Patients With COPD
- 1 March 2006
- Vol. 129 (3) , 509-517
- https://doi.org/10.1378/chest.129.3.509
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPDEuropean Respiratory Journal, 2005
- Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary diseaseThorax, 2003
- Bronchodilator reversibility testing in chronic obstructive pulmonary diseaseThorax, 2003
- Long-acting β2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?Current Opinion in Pharmacology, 2003
- A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- Measurement of Symptoms, Lung Hyperinflation, and Endurance during Exercise in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Routine Nebulized Ipratropium and Albuterol Together Are Better Than Either Alone in COPDChest, 1997
- Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.American Journal of Respiratory and Critical Care Medicine, 1995
- Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.Thorax, 1995
- Lung Function Testing: Selection of Reference Values and Interpretative StrategiesAmerican Review of Respiratory Disease, 1991